Tag : multiple sclerosis (ms)

Neurology

Maintaining Multiple Sclerosis Care With Virtual Visits

Newsemia
Dr Stephen Krieger provides tips for monitoring patients, buoying their spirits, and keeping them healthy when in-office visits aren’t an option. Medscape Neurology Source link...
Neurology

High-Profile MS Neurologist Struck by Motorcycle

Newsemia
A noted UK neurologist and multiple sclerosis researcher has sustained significant injuries after being struck by a motorcycle while out running. Medscape Medical News Source...
Neurology

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

Newsemia
People with multiple sclerosis and two vascular comorbidities showed significantly lower gray matter and neurofunctional status vs those with no such comorbidities. Medscape Medical News...
Neurology

Twelve Medical Groups Oppose UHC Copay Accumulator Program

Newsemia
In an Oct. 7 letter to UHC, the 12 groups acknowledged that the drugs targeted by the accumulator policy are expensive. "However, they are also...
Neurology

Shocking Rate of Caregiver Abuse in Adults With Advanced MS

Newsemia
More than half of patients with advanced multiple sclerosis report mistreatment by their unpaid caregiver, with psychological and financial abuse the most common. Medscape Medical...
Neurology

End of the Road for High-Dose Biotin in MS?

Newsemia
High-dose biotin, a B vitamin used at lower doses as a food supplement, does not significantly improve disability or walking speed in patients with progressive...
Neurology

Newer DMTs More Effective vs Injectables in Pediatric MS

Newsemia
Researchers examined data from 7 tertiary pediatric neurology centers in the UK and identified patients under age 18 with relapsing-remitting MS who were treated with...
Neurology

Alemtuzumab: Prior Autoimmunity Does Not Predict Adverse Events

Newsemia
There’s no evidence to support the idea that previous autoimmunity before or after alemtuzumab predicts subsequent rare but serious autoimmune events recently linked to the...
Neurology

Safety Concern With Fingolimod to Ocrelizumab Switch in MS

Newsemia
A new study has suggested that some patients who make this switch may experience "double immunosuppression" – very low levels of both T and B...
Neurology

Researchers Identify Five Cognitive Phenotypes in MS

Newsemia
Researchers have identified five cognitive phenotypes among patients with multiple sclerosis, which can help drive tailored rehabilitative strategies, say researchers. Medscape Medical News Source link...
Neurology

Optimal Dose of Fingolimod for Multiple Sclerosis Confirmed

Newsemia
The 0.5-mg dose of fingolimod provides a greater reduction in annualized relapse rate vs both the 0.25-mg dose of fingolimod and the 20-mg dose of...
Neurology

B Cell Test Predicts Alemtuzumab Autoimmunity in MS

Newsemia
Analyzing B cell counts before treatment could help select patients for the drug, a new study suggests. Medscape Medical News Source link...
Neurology

High Plasma GFAP Level Predicts Disability in Progressive MS

Newsemia
A high level of glial fibrillary acidic protein (GFAP) in the blood may predict worsening disability in patients with secondary progressive multiple sclerosis (MS), according...
Neurology

Masitinib Impresses in 'Nonactive' Progressive MS

Newsemia
The drug, with a completely new mechanism of action for multiple sclerosis, slowed disability in nonactive primary and secondary progressive forms of the disease, where...
Neurology

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

Newsemia
There is now no doubt that a prodromal phase of MS exists for several years before the first demyelinating event occurs, latest evidence shows. Medscape...
Neurology

NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Newsemia
Measuring levels of neurofilament light chain is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple sclerosis,...
Neurology

App for MS Aims to Capture Elusive Signals of Progression

Newsemia
Investigators in Switzerland are testing an application for smartphones that they hope will elucidate subtle signs of disease progression in multiple sclerosis (MS) — beyond...
Neurology

Lessons for Patients With MS and COVID-19

Newsemia
Two lessons about managing patients with MS and COVID-19 have emerged: Combined PCR and serology helped avoid disease reactivation in asymptomatic carriers during the pandemic...
Neurology

In MS, Serious AEs More Common in Rituximab vs Ocrelizumab

Newsemia
Medscape Medical News Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy